Log In
Print
BCIQ
Print
Print this Print this
 

AUNP12

  Manage Alerts
Collapse Summary General Information
Company Aurigene Discovery Technologies Ltd.
DescriptionA programmed cell death 1 (PDCD1; PD-1; CD279) peptide antagonist
Molecular Target Programmed cell death 1 (PDCD1) (PD-1) (CD279)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner

Laboratoires Pierre Fabre S.A.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today